Douglas B Evans Selected Research

Cosyntropin (Cortrosyn)

3/2022	Utility of Epinephrine Levels in Determining Adrenal Vein Cannulation During Adrenal Venous Sampling for Primary Aldosteronism.
1/2022	Selective Glucocorticoid Replacement Following Unilateral Adrenalectomy for Hypercortisolism and Primary Aldosteronism.
1/2016	Cosyntropin stimulation testing on postoperative day 1 allows for selective glucocorticoid replacement therapy after adrenalectomy for hypercortisolism: Results of a novel, multidisciplinary institutional protocol.
1/2016	Response to comments on: Cosyntropin stimulation testing on postoperative day 1 allows for selective glucocorticoid replacement therapy following adrenalectomy for hypercortisolism: Results of a novel, multidisciplinary institutional protocol.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Douglas B Evans Research Topics

Disease

109	Pancreatic Neoplasms (Pancreatic Cancer) 05/2021 - 01/2002
89	Neoplasms (Cancer) 01/2022 - 04/2002
61	Adenocarcinoma 01/2022 - 01/2002
23	Neoplasm Metastasis (Metastasis) 01/2019 - 01/2003
16	Primary Hyperparathyroidism 01/2022 - 12/2002
11	Thyroid Neoplasms (Thyroid Cancer) 01/2022 - 07/2004
9	Disease Progression 10/2018 - 03/2006
8	Pheochromocytoma 01/2022 - 04/2003
7	Carcinogenesis 05/2009 - 09/2002
6	Margins of Excision 10/2008 - 12/2004
5	Papillary Thyroid Cancer 09/2018 - 08/2007
5	Multiple Endocrine Neoplasia Type 2a (MEN 2) 01/2013 - 04/2003
4	Adenoma (Adenomas) 08/2022 - 10/2008
4	Hyperaldosteronism (Conn Syndrome) 03/2022 - 01/2016
4	Lymphadenopathy 11/2018 - 03/2006
4	Carcinoma (Carcinomatosis) 11/2014 - 12/2004
4	Hyperparathyroidism 05/2013 - 04/2003
3	Adrenal Insufficiency (Adrenal Gland Hypofunction) 01/2022 - 02/2013
3	Cushing Syndrome 01/2022 - 01/2016
3	Hyperplasia 01/2020 - 12/2003
3	Hypocalcemia 10/2018 - 12/2012
3	Thyroiditis 10/2018 - 11/2013
3	Lymphatic Metastasis 01/2017 - 07/2007
3	Inflammation (Inflammations) 01/2017 - 11/2003
3	Adrenocortical Carcinoma 06/2014 - 12/2007
2	Thyroid Diseases (Thyroid Disease) 01/2022 - 10/2011
2	Pancreatitis 01/2017 - 12/2007
2	Obesity 05/2016 - 03/2009
2	Hypercalcemia (Milk Alkali Syndrome) 01/2016 - 08/2004
2	Sinistral Portal Hypertension 05/2014 - 07/2013
2	Neutropenia 03/2014 - 01/2002
2	Weight Loss (Weight Reduction) 03/2014 - 04/2002
2	Multiple Endocrine Neoplasia (Multiple Endocrine Adenomatosis) 01/2013 - 06/2005
2	medullary Thyroid cancer 12/2010 - 07/2008
2	Neuroendocrine Tumors (Neuroendocrine Tumor) 06/2008 - 04/2007

Drug/Important Bio-Agent (IBA)

13	NF-kappa B (NF-kB)IBA 10/2009 - 09/2002
11	Gemcitabine FDA Link 04/2009 - 04/2002
10	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2007 - 01/2003
8	Messenger RNA (mRNA)IBA 01/2022 - 03/2003
8	Proteins (Proteins, Gene)FDA Link 02/2011 - 03/2003
7	CalciumIBA 01/2022 - 08/2004
7	Parathyroid Hormone (Parathormone)IBA 10/2018 - 12/2012
6	Biological ProductsIBA 01/2020 - 05/2003
6	DNA (Deoxyribonucleic Acid)IBA 01/2018 - 01/2003
6	Fluorouracil (Carac)FDA LinkGeneric 03/2014 - 04/2002
6	Transcription Factors (Transcription Factor)IBA 05/2009 - 09/2002
5	LigandsIBA 01/2017 - 12/2003
5	Antineoplastic Agents (Antineoplastics)IBA 03/2007 - 01/2003
4	Cosyntropin (Cortrosyn)FDA LinkGeneric 03/2022 - 01/2016
4	CarbohydratesIBA 01/2020 - 07/2010
4	Phosphotransferases (Kinase)IBA 10/2009 - 01/2005
4	Monoclonal AntibodiesIBA 04/2007 - 01/2003
4	Codon (Codons)IBA 01/2007 - 04/2003
4	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 06/2005 - 12/2003
3	Thyroglobulin FDA Link 01/2022 - 08/2007
3	GlucocorticoidsIBA 01/2022 - 01/2016
3	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2022 - 12/2007
3	AntigensIBA 01/2020 - 10/2015
3	Biomarkers (Surrogate Marker)IBA 01/2020 - 01/2018
3	ChemokinesIBA 01/2017 - 01/2014
3	CytokinesIBA 01/2017 - 01/2003
3	Tumor Biomarkers (Tumor Markers)IBA 06/2009 - 10/2005
3	Small Interfering RNA (siRNA)IBA 05/2009 - 05/2005
3	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 03/2007 - 07/2004
3	IGF Type 1 Receptor (IGF 1 Receptor)IBA 07/2006 - 09/2003
3	Interleukin-8 (Interleukin 8)IBA 01/2006 - 01/2003
2	CatecholaminesIBA 01/2022 - 06/2007
2	Protein Isoforms (Isoforms)IBA 01/2021 - 05/2005
2	Pharmaceutical PreparationsIBA 01/2018 - 01/2002
2	Vitamin D FDA LinkGeneric 05/2016 - 12/2008
2	Adrenal Cortex Hormones (Corticosteroids)IBA 02/2013 - 04/2004
2	Calcitonin (Calcitonin, Eel)FDA LinkGeneric 01/2013 - 12/2003
2	IodineIBA 12/2012 - 06/2009
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 02/2011 - 03/2007
2	Mitotane (Lysodren)FDA Link 01/2010 - 12/2007
2	AgarIBA 10/2009 - 02/2008
2	Interferon-alpha (Interferon Alfa)IBA 08/2008 - 05/2003
2	Cisplatin (Platino)FDA LinkGeneric 08/2008 - 07/2008
2	MetalsIBA 07/2008 - 11/2005

Therapy/Procedure

63	Therapeutics 05/2021 - 01/2002
37	Neoadjuvant Therapy 12/2021 - 01/2002
24	Pancreaticoduodenectomy 12/2019 - 05/2002
23	Radiotherapy 05/2021 - 04/2002
20	Parathyroidectomy 08/2022 - 12/2002
19	Drug Therapy (Chemotherapy) 05/2021 - 01/2002
17	Thyroidectomy 11/2020 - 04/2003
10	Adrenalectomy 01/2022 - 04/2004
9	Pancreatectomy 04/2021 - 03/2005
8	Neck Dissection (Radical Neck Dissection) 11/2018 - 07/2007
5	Operative Time 12/2012 - 04/2007
4	Stents 12/2019 - 11/2005
4	Length of Stay 01/2018 - 04/2002
4	Decompression 07/2013 - 11/2005
3	Ligation 05/2014 - 12/2008
3	Lymph Node Excision (Lymph Node Dissection) 07/2007 - 05/2005
3	Operative Surgical Procedures 07/2007 - 12/2004
2	Surgical Splenorenal Shunt (Splenorenal Shunt) 01/2019 - 07/2013
2	Laparotomy 02/2015 - 05/2014
2	Adjuvant Radiotherapy 11/2014 - 08/2004
2	Contraindications 05/2014 - 04/2010